The development and optimization of an efficient conjugation process involves identifying the critical quality attributes and monitoring critical process parameters.
Srinath Thirumalairajan
Advertisement
Srinath Thirumalairajan, PhD, is senior director of GMP Manufacturing; Jesse Novak is a bioconjugation scientist at Abzena.
Articles by Srinath Thirumalairajan
Advertisement
Latest Updated Articles
QbD in the Development of ADCs with PBD Dimer WarheadsPublished: September 1st 2018 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
2
Regulatory Challenges for Global Manufacturing of Vaccines
3
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
4
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
5
